Progesterone is essential for maintenance and growth of uterine leiomyoma. - Wikidata - awgldk - TriplyDB

Progesterone is essential for maintenance and growth of uterine leiomyoma.

Progesterone is essential for maintenance and growth of uterine leiomyoma.

http://www.wikidata.org/entity/Q33874391

about

Selective progesterone receptor modulators (SPRMs) for uterine fibroids Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation Medical treatment of uterine leiomyoma An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control Recent Advances in Uterine Fibroid Etiology.Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomas Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer The androgen receptor mediates antiapoptotic function in myometrial cells Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.Role of stem cells in human uterine leiomyoma growth.The characteristics of bone marrow-derived endothelial progenitor cells and their effect on glioma.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Bioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer.Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis Measurement of phenolic environmental estrogens in women with uterine leiomyoma.The role of progesterone signaling in the pathogenesis of uterine leiomyoma Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women.Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.Innovative oral treatments of uterine leiomyoma Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation.Epidemiology of Uterine Fibroids: From Menarche to Menopause.Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.Estrogen receptors and human disease: an update.Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids.Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model Low dose mifepristone in medical management of uterine leiomyoma - an experience from a tertiary care hospital from north India

P2860

Q24197801-AB83F99B-7454-4A1E-B3C0-606218D1FDDA Q24567733-8AAA6E05-50A2-43A1-A1A1-5AA703488D9B Q26765991-4394EC83-BCA8-40D7-AEFA-2D580E85C2B9 Q26824379-ED946CF3-627E-4FF0-A973-8AA22785AFE8 Q28487526-0CBD5FBA-C601-4A2B-B4AC-6B32A2AD1CA2 Q30407678-0B53D37A-0E01-4FDF-B4B2-3730EE9AADBC Q30411083-3F9A3460-E879-4C5B-A9DC-C5EB7FB84CB5 Q33627092-25F4ECA2-FC01-48A6-81EB-DEEA4261CB25 Q33832224-28493F75-9554-4068-A76D-0A62A47C2861 Q33852886-BFCF1D16-9507-49F7-918A-1E1BD95AE927 Q33876546-BADCB4B1-64B5-404A-B095-EA707F2953C1 Q33908395-70C6C28F-EF0D-4011-9C8B-AE5016742D90 Q34007815-D8CB9374-44E6-4CA2-A1F4-983BB770EE67 Q34137268-1CF61ECD-C675-445D-AD46-75CCC44B9E95 Q34263429-0529B9E3-C0D6-4DB1-9D54-3D6DF698B8BB Q34312566-A6F3D187-5C96-4681-AAB2-D07B19BD0D94 Q34321877-54D09BA6-F652-4FF2-B7D9-A1B44D89F065 Q34437666-A37CF4D5-E124-4D49-8147-105581F30C41 Q34568706-07515998-1ED1-4867-B94E-CBAC61A439AE Q34776859-7992B2D6-1337-4239-8705-07ABC906A3E4 Q35047452-EB3733D6-7C81-4699-A4A1-D1DCDD9BCCAC Q35249360-CB69BAF3-E06C-414A-BF91-F73F1B56A4D4 Q35442024-28417C5A-E5E8-4EBD-A0AF-707F459B2F38 Q35551056-99CA12DB-F220-48AA-9E2A-091C4A17842A Q35617355-E5D2C3E4-7E37-41BA-80CF-A6899738CA79 Q35662059-2D9CD6E8-3D3F-4447-9A5A-7D6D70615D8E Q35812468-552C00CC-D4E6-4614-9E4B-96469D308F9D Q35837820-728B54EF-DB51-44F4-B4A4-F4C3824B3955 Q35847355-A6F58A61-6E4D-47FA-A825-21FC76050400 Q35855640-91013872-13AF-4644-AC98-D122D1316AB2 Q35901096-E24C6B9B-F402-47F0-BFC8-8D6D9DE96080 Q35944399-DD885D90-FF63-49CF-A044-1EDED48F67D3 Q36298532-9801EEBE-069E-4C4F-960C-6FD111CE7AF9 Q36522644-32AC70F0-A698-4A0B-ACF2-B8496A92126F Q36525065-AA124202-3565-478B-8AC0-13596D9DE638 Q36661810-15D77136-FBA2-4F44-85FC-BD408555B23F Q36723027-D12CC3F4-A01F-4A82-BE92-5B1A97813E93 Q36789291-5AB51119-1EC2-49A1-8ABF-15F47CC5ADAD Q36991838-7EA1A5A0-0AFA-4FF1-B7ED-F35602ED1A3F Q37073241-81995D55-8A81-4FA0-AD79-040EE5A02E0C

P2860

Progesterone is essential for maintenance and growth of uterine leiomyoma.

http://www.wikidata.org/entity/Q33874391

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Progesterone is essential for maintenance and growth of uterine leiomyoma.

@ast

Progesterone is essential for maintenance and growth of uterine leiomyoma.

@en

type

label

Progesterone is essential for maintenance and growth of uterine leiomyoma.

@ast

Progesterone is essential for maintenance and growth of uterine leiomyoma.

@en

prefLabel

Progesterone is essential for maintenance and growth of uterine leiomyoma.

@ast

Progesterone is essential for maintenance and growth of uterine leiomyoma.

@en

P1433

Q33874391-4B2682BE-9664-4223-9B32-6406958B1C8F

P1476

Q33874391-1FA42CAF-5529-4AA6-B48F-29D2B6EE501E

P2093

Q33874391-22BDF5BA-EE62-47BE-8033-8171D24EED5D

Q33874391-373E2839-702B-47A5-BE73-69F1751C73BC

Q33874391-7C2748B2-DFF3-4151-9C91-995F0786B974

Q33874391-86165E8F-65CE-45C2-A51F-87F5A97437CE

Q33874391-A91CBBAC-E3D2-41DF-A48F-5615C3F6602B

P2860

Q33874391-145BC53D-B838-4081-A6FA-A46C168508E6

Q33874391-1DE8238D-EF52-4CFF-92DF-C96FD3D628F9

Q33874391-274D744A-CA45-41E1-A2AA-CB3FC8AFD211

Q33874391-2AFB01D8-598E-4EFA-89A0-CEC54BD6BEA6

Q33874391-2D64D686-84FE-4896-9FB8-A94ADBE5C6EB

Q33874391-3559CF8B-53D2-41E7-8D09-6B45405ADB4F

Q33874391-36BC9180-866C-4B0D-A951-5E9617CB2B18

Q33874391-384DA314-3CC6-49AC-B0CE-6A86E498ECF4

Q33874391-3D500027-DF44-4EE4-937A-41A4174C8321

Q33874391-3F5A798C-28FC-4935-B8C0-506AB9CD6933

P304

Q33874391-7F9CAC7B-9655-414B-A90D-A6726B050B28

P31

Q33874391-346BE85C-5A21-4935-A1E6-10FD2F18D09E

P356

Q33874391-390FD41B-71DC-4D0F-AFA2-92422FE4B386

P407

Q33874391-888C6EA8-6A4F-4286-8B4E-EBF5FFF6F724

P433

Q33874391-E5A77ABC-4913-40FD-907A-6559DBBB1C12

P478

Q33874391-E8BCD8CB-92DF-4FA6-97CB-27B2DAB57771

P50

Q33874391-A9138C15-F97A-43DA-A243-65BD9F852586

P577

Q33874391-7C6034D8-F04B-4019-8DF5-7576A774F16C

P5875

Q33874391-5FAD024E-96F9-41E7-B894-A46D036FA8B0

P698

Q33874391-11285A51-FF5B-4B72-BD86-B4368D5B9E33

P932

Q33874391-FCFC7FBC-B342-423D-803E-A2E5D5C5C8CB

P356

P1433

P1476

Progesterone is essential for maintenance and growth of uterine leiomyoma

@en

P2093

Hiroshi Ishikawa

http://www.w3.org/2001/XMLSchema#string

Kazutomo Ishi

http://www.w3.org/2001/XMLSchema#string

Rafael Kakazu

http://www.w3.org/2001/XMLSchema#string

Serdar E Bulun

http://www.w3.org/2001/XMLSchema#string

Vanida Ann Serna

http://www.w3.org/2001/XMLSchema#string

P2860

Selective estrogen receptor modulators (SERMs) for uterine leiomyomas

Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

Transmembrane crosstalk between the extracellular matrix--cytoskeleton crosstalk

A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells

Taking cell-matrix adhesions to the third dimension

Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse.

Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains.

17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway.

High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

P304

2433-2442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2009-1225

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43073149

http://www.w3.org/2001/XMLSchema#string

P698

20375184

http://www.w3.org/2001/XMLSchema#string

P932

2875812

http://www.w3.org/2001/XMLSchema#string